Monoclonal Anti-LSD1 (AOF2) (mouse IgG1 isotype) is derived from the hybridoma LSD1-12 produced by the fusion of mouse myeloma cells (NS1) and splenocytes from BALB/c mice. Lysine specific demethylase 1 (LSD1) also known as amine oxidase flavin-containing domain 2 (AOF2) () is a lysine-specific demethylase. It is a nuclear protein containing a SWIRM (Swi3p, Rsc8p and Moira) domain, a flavin adenine dinucleotide (FAD)-binding motif and an amine oxidase domain. The LSD1 gene is mapped to human chromosome 1p36.12. LSD1 is referred to by additional names including KDM1A protein, BHC110(BRAF-HDAC complex protein 110) and nuclear polyamine oxidase (NPAO)().
Lysine Specific Demethylase 1 (LSD1) is a component of several histone deacetylase complexes that function through modifying chromatin structure to repress transcription.LSD1 action can signal either activation or repression of transcription. Demethylation of histone H3 Lys4 by LSD1 leads to transcriptional repression of target genes, while demethylation of histone H3 at Lys9 leads to depression of androgen receptor target genes. The activity of LSD1 (AOF2) is regulated by its associated factors namely, corepressor to the REST (RE1 silencing transcription factor/neural restrictive silencing factor)(CoREST). This, in turn, promotes demethylation by enhancing the association of LSD1 with the nucleosomes and also protects LSD1 from proteasomal degradation. LSD1 is a component of nucleosome remodeling and deacetylase (NuRD). It regulates neuronal development and favors neural stem cell proliferation. It highly expressed in acute myeloid leukemia and many solid tumors.
